APELLIS PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for APELLIS PHARMACEUTICALS INC NOTE 3.500% 9/1, CUSIP 03753UAB2.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for APELLIS PHARMACEUTICALS INC NOTE 3.500% 9/1, CUSIP 03753UAB2.